TDC
MEDP icon

Thompson Davis & Co’s Medpace MEDP Stock Holding History

Thompson Davis & Co’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$9K Buy
+150
New +$8.21K 0.02% 476

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thompson Davis & Co's MEDP Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Medpace (MEDP) in Q3 2018: 150 shares worth $9K. The stake represents 0.02% of the portfolio and ranks #476 among its holdings.

207 funds tracked by Wall St. Rank hold MEDP as of Q3 2018.

  • Thompson Davis & Co held 150 shares of Medpace worth $9K as of Q3 2018.
  • Medpace was a new Thompson Davis & Co position in Q3 2018.
  • Medpace made up 0.02% of Thompson Davis & Co's portfolio in Q3 2018, its #476 holding.
  • 207 funds tracked by Wall St. Rank held Medpace as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.